In this issue:
ROCKET-IGNITE & HORIZON:rocatinlimab efficacious for AD
Risk factors for persistent AD phenotype identified
Less frequent maintenance dosing of rademikibart similarly efficacious
Ruxolitinib cream may be a novel therapy for non-atopic CHE
Could prenatal high-dose vitamin D protect against childhood AD in mothers who smoke?
Paediatric AD linked to long-term impact on personal relationships
Evaluation of the reliability of AD clinical scoring systems
Significant racial/ethnic disparities in access to advanced therapy in the US
Vaccination recommendations for patients with AD undergoing JAK inhibitor treatment
Mineral salts + antioxidants a promising alternative therapy
Please login below to download this issue (PDF)